
The AI-Native Practice Playbook: Why Epsilon Health Built a Medical Group Instead of Selling Software
Dr. Dereck Mush, MD, MBA
No. 24 Investors
Managing Partner, Venture Valkyrie • United States
Seasoned venture capitalist, advisor, and health tech industry commentator.
Find on LinkedInKnown for her pragmatic and witty analysis, she has spent decades advising boards and publishing candid market commentaries that help industry leaders separate digital health hype from reality.
Seasoned venture capitalist, advisor, and health tech industry commentator.
Known for her pragmatic and witty analysis, she has spent decades advising boards and publishing candid market commentaries that help industry leaders separate digital health hype from reality.
Loading the full dossier
Audience size across LinkedIn, X, YouTube, podcasts and newsletters.
How much the audience actually reacts, comments, shares and subscribes.
Clinical, research, operating or investing track record behind the commentary.
Publishing cadence and how reliably they show up with original work.
Whether decision makers, policy and capital actually move on what they say.
Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.
Christina FarrFounder and CEO, Second Opinion Media / Scrub Capital
Julie YooGeneral Partner, Andreessen HorowitzChange, add or remove details on this profile. Our desk reviews every request.
This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAKeep exploring